Africa Opensource Pharma & Medicine

De-Fi platform leveraging stake pools to crowdfund open-source drug/medical projects, where scientific collaboration & governance is central

Extensive exp in health/life sciences, academia, & deep understanding of the industry. Several scientific/tech advisors with decades of exp.

Overview of recent progress

We are building on our successful bid in Fund 5 (see the previous Fund 5 proposal here:****https://cardano.ideascale.com/a/dtd/Africa-Opensource-Pharma-Medicine/352738-48088)and are close to releasing the MVP which is implemented utilising Plutus.

We expect to have this available before the end of Fund 6 being finalised and will look to launch this with the decentralised tuberculosis drug screening project with some of our key partners (H3D in South Africa, and CRI/INSERM in Europe. Additional partners in Africa e.g. Kumasi Hive in Ghana, MRC Gambia, pioneering labs participating in the "Africa Grand Challenges" drug discovery initiative) will be onboarded onto the Fleming ecosystem by the end of this year, or early next year. We will add it in the comments section and our Discord for review.

Please also join our Discord as we would love to actively work with the Cardano community to ensure the success of Fleming Protocol in Africa. This is where you can keep up with our latest progress, and where we plan to share our revised whitepaper, plans/timelines for an****Initial Stake Pool Offering (ISO), and tokenomics/govenrance proposal.

Fleming Protocol was recently selected to join the highly competitive Outlier Ventures Base Camp accelerator (https://outlierventures.io/base-camp/), who believe strongly in our vision for drug and medical discovery in Africa. This is exciting news as this will allow us to access their wealth of expertise/experience in the blockchain/Web 3 space (e.g. expertise in go to market strategies, token sale structuring, technical, tokenomics and legal expertise etc) and will open up many doors for more funding amongst other things. As we are likely to incorporate IPFS decentralised data storage as part of Fleming Protocol, we'll also, as a result of the accelerator, have access to the support and expertise of Protocol Labs (https://protocol.ai/), who have extensive and valuable experience building the next generation of decentralised internet applications (e.g. Filecoin, IPFS etc). The accelerator started in early September 2021 and lasts until the end of the year.

Overview of Fleming Protocol

Fleming Protocol is a decentralised, open-source drug discovery ecosystem that connects scientists, crowd investors and institutions, enabling the most impactful research to be translated into real-world therapeutics and devices. We believe that such a platform will have tremendous utility in helping Africa overcome its shortfall in pharma/medical R&D and production.

The open-source nature will allow open access to trained scientists within Africa, who can share their expertise in one central respiratory, but also utilise a growing global network of leading scientists/institutions e.g. Inserm, Center for Research and Interdisciplinarity (CRI), University of Paris, independent scientists from the citizen science-based JOGL platform, and members/institutions associated with the Open Source Pharma Foundation.

Fleming's cryptoeconomics will present new funding opportunities for open-source R&D, making such efforts sustainable over the long term. Our focus on Africa will allow Cardano stakeholders, with an interest in the region, to support R&D projects that have the potential to create a self-sustaining industry within the continent, and thus reducing Africa's disease burden.

Our ambition is to leverage capital generated from the Fleming ecosystem to jump-start local R&D, provide generic drug manufacturing capabilities and ancillary methods to create safe, effective and available local sources.

We are developing this ecosystem in close collaboration with academic scientists as well as citizen science organisations, e.g. the University of Cape-Town/H3D and the Center for Research and Interdisciplinarity (CRI) in Paris. This will allow us to build and adapt the infrastructure to host projects ranging from small community-based solutions to large academic drug discovery efforts. These R&D projects would be within the realm of conditions that burden the continent the most.

Please, join our Discord: https://discord.gg/kxmHu5HE

How do we plan to spend Fund 6 funds?

This will go almost exclusively to paying our engineering team, who have a wealth of experience in Haskell and are working extremely hard to develop and launch our MVP on Plutus. Anything left over will be used to raise the profile and brand of Fleming Protocol with the relevant communities.